BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

Looking ahead, Leen Kawas believes that the successful integration of AI into drug discovery will require thoughtful ...

Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

Based on Intelligencia AI’s comprehensive, proprietary database of over 20,000 industry-sponsored, interventional oncology clinical programs (around 12,400 clinical trials), recent insights highlight ...

A generic product cannot enter the market until the originator product’s IP has expired, but the development process can take ...

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said founder Alex Zhavoronkov. Insilico Medicine, an AI drug discovery company ...

Global harmonization of CMC guidelines is a key focus for top pharmaceutical consultants. Variations in regulatory requirements across regions often create inefficiencies in drug development—for ...

A Germany-based mid-sized pharma company actively engaged in the late-stage development of a therapy for Primary Immunodeficiency (PID) and, with a strong marketing and drug commercialization ...